247 related articles for article (PubMed ID: 16170505)
41. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
[TBL] [Abstract][Full Text] [Related]
42. Extended resections for hilar cholangiocarcinoma.
Neuhaus P; Jonas S; Bechstein WO; Lohmann R; Radke C; Kling N; Wex C; Lobeck H; Hintze R
Ann Surg; 1999 Dec; 230(6):808-18; discussion 819. PubMed ID: 10615936
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
44. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma.
Gurmikov BN; Vishnevsky VA; Kovalenko YA; Chzhao AV
Khirurgiia (Mosk); 2020; (5):5-11. PubMed ID: 32500683
[TBL] [Abstract][Full Text] [Related]
45. Complete resection of the caudate lobe of the liver with tumor: technique and experience.
Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Yu YQ
Hepatogastroenterology; 2001; 48(39):808-11. PubMed ID: 11462929
[TBL] [Abstract][Full Text] [Related]
46. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
[TBL] [Abstract][Full Text] [Related]
47. Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.
Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Okabe H; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Yoshizumi T; Maehara Y; Baba H
Anticancer Res; 2017 Dec; 37(12):6971-6975. PubMed ID: 29187482
[TBL] [Abstract][Full Text] [Related]
48. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study.
Tan JW; Hu BS; Chu YJ; Tan YC; Ji X; Chen K; Ding XM; Zhang A; Chen F; Dong JH
World J Surg; 2013 Mar; 37(3):614-21. PubMed ID: 23283218
[TBL] [Abstract][Full Text] [Related]
49. [Re-resection for recurrent intrahepatic cholangiocarcinoma].
Murakami S; Ajiki T; Okazaki T; Matsumoto T; Yoshida Y; Shinozaki K; Goto T; Asari S; Shinzeki M; Kido M; Matsumoto I; Fukumoto T; Ku Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1468-70. PubMed ID: 25731221
[TBL] [Abstract][Full Text] [Related]
50. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
51. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
52. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors.
Ellis MC; Cassera MA; Vetto JT; Orloff SL; Hansen PD; Billingsley KG
HPB (Oxford); 2011 Jan; 13(1):59-63. PubMed ID: 21159105
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
[TBL] [Abstract][Full Text] [Related]
55. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
56. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma.
Uchiyama K; Nakai T; Tani M; Onishi H; Kinoshita H; Kawai M; Ueno M; Yamaue H
Arch Surg; 2003 Sep; 138(9):1012-6. PubMed ID: 12963661
[TBL] [Abstract][Full Text] [Related]
57. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K
Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711
[TBL] [Abstract][Full Text] [Related]
58. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.
Farges O; Fuks D; Boleslawski E; Le Treut YP; Castaing D; Laurent A; Ducerf C; Rivoire M; Bachellier P; Chiche L; Nuzzo G; Regimbeau JM
Ann Surg; 2011 Nov; 254(5):824-29; discussion 830. PubMed ID: 22042474
[TBL] [Abstract][Full Text] [Related]
59. Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience.
Igami T; Nishio H; Ebata T; Yokoyama Y; Sugawara G; Nimura Y; Nagino M
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):449-54. PubMed ID: 19806294
[TBL] [Abstract][Full Text] [Related]
60. Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value?
Wahab MA; Sultan AM; Salah T; Fathy O; Elebidy G; Elshobary M; Shiha O; Rauf AA; Elhemaly M; El-Ghawalby N
Hepatogastroenterology; 2012; 59(114):321-4. PubMed ID: 22328268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
